Share Share Share

Improving the efficacy of proteasome inhibitors in the treatment of renal cell carcinoma by combination with the human immunodeficiency virus (HIV)-protease inhibitors lopinavir or nelfinavir

BJU INTERNATIONAL

Abt, D; Besse, A; Sedlarikova, L; Kraus, M; Bader, J; Silzle, T; Vodinska, M; Slaby, O; Schmid, HP; Engeler, DS; Driessen, C; Besse, L, 2018: Improving the efficacy of proteasome inhibitors in the treatment of renal cell carcinoma by combination with the human immunodeficiency virus (HIV)-protease inhibitors lopinavir or nelfinavir. BJU INTERNATIONAL 121(4), p. 600 - 609, doi: 10.1111/bju.14083

Research Groups:

• Molecular Oncology - Solid Cancer

CEITEC authors:

• Martina Vodinská
• Prof. Ondřej Slabý, Ph.D.